
Sign up to save your podcasts
Or


Rob Schutz didn't expect to be working on a startup addressing the need for reliable, direct-to-consumer erectile dysfunction therapeutics, but that's where he ended up at Roman. The company has since pivoted to become 'Ro,' with a focus on digital health and telemedicine more broadly, as well as pharmacy services, but we talk to Schutz about how he went from Bark Box to human health, and what the experience of building his startup alongside his two cofounders was like.
Links for this episode:
Connect with us:
Found posts every Tuesday. Subscribe on Apple, Spotify or wherever you listen to podcasts to be alerted when new episodes drop. Check out the other TechCrunch podcast: Equity . Subscribe to Found to hear more stories from founders each
Connect with us:
By TechCrunch4.3
2323 ratings
Rob Schutz didn't expect to be working on a startup addressing the need for reliable, direct-to-consumer erectile dysfunction therapeutics, but that's where he ended up at Roman. The company has since pivoted to become 'Ro,' with a focus on digital health and telemedicine more broadly, as well as pharmacy services, but we talk to Schutz about how he went from Bark Box to human health, and what the experience of building his startup alongside his two cofounders was like.
Links for this episode:
Connect with us:
Found posts every Tuesday. Subscribe on Apple, Spotify or wherever you listen to podcasts to be alerted when new episodes drop. Check out the other TechCrunch podcast: Equity . Subscribe to Found to hear more stories from founders each
Connect with us:

1,289 Listeners

542 Listeners

176 Listeners

4,878 Listeners

1,095 Listeners

2,370 Listeners

2,162 Listeners

342 Listeners

3,976 Listeners

227 Listeners

209 Listeners

2,667 Listeners

293 Listeners

187 Listeners

210 Listeners

25 Listeners

5 Listeners

3 Listeners